Related Experiment Video
Updated: Sep 13, 2025
Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion
Yiman Wang1,2,3, Ke Liu1,2,3, Yuxin Zhang1,2,3
1Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany.
Abstract:
Melanoma is an aggressive skin cancer and highly lethal at advanced stages due to its high tumorigenicity and metastatic capacity. Changing the phenotype of cancer cells from one lineage to another, a process called transdifferentiation, leads to tumor cell reversion, which goes along with a drastic reduction of their tumorigenicity. Via ectopic overexpression of four neuronal transcription factors, we transdifferentiated melanoma cells into neuron-like cells expressing neuronal markers and showing a neuron-like morphology. Moreover, the tumorigenic and metastatic potential of transdifferentiated cells in vitro and in vivo was significantly reduced. Transdifferentiated cells were also more sensitive to radiotherapy compared with their parental counterparts. We conclude that transdifferentiation of cancer cells into terminally differentiated neuron-like cells might represent a prospective new therapeutic approach for the treatment of melanoma.
Insights
Transdifferentiating melanoma cells into neuron-like cells drastically reduces their tumor-forming and metastatic potential. This novel approach also increases sensitivity to radiotherapy, offering a potential new melanoma treatment.
Area of Science:
- Oncology
- Cell Biology
- Neuroscience
Background:
- Melanoma is an aggressive skin cancer with high lethality in advanced stages.
- High tumorigenicity and metastatic capacity contribute to melanoma's poor prognosis.
- Cellular phenotype plasticity, including transdifferentiation, can reverse cancer progression.
Purpose of the Study:
- To investigate the therapeutic potential of transdifferentiating melanoma cells into neuron-like cells.
- To assess the impact of transdifferentiation on melanoma cell tumorigenicity, metastatic capacity, and radiosensitivity.
Main Methods:
- Ectopic overexpression of four specific neuronal transcription factors in melanoma cells.
- Induction of transdifferentiation towards a neuron-like phenotype, confirmed by marker expression and morphology.
- In vitro and in vivo evaluation of tumorigenic and metastatic potential of transdifferentiated cells.
- Assessment of radiosensitivity in transdifferentiated versus parental melanoma cells.
Main Results:
- Melanoma cells were successfully transdifferentiated into neuron-like cells.
- Transdifferentiated cells exhibited reduced tumorigenicity and metastatic potential in vitro and in vivo.
- Transdifferentiated melanoma cells showed increased sensitivity to radiotherapy compared to controls.
Conclusions:
- Transdifferentiation of melanoma cells into neuron-like cells significantly impairs their malignant characteristics.
- This approach offers a promising new therapeutic strategy for melanoma treatment.
- Further research into transdifferentiation-based therapies for melanoma is warranted.
